Evidence map›Paper›PMID 22540737›Full record

ArticleCombinatorial chemistry & high throughput screening2012

An image-based biosensor assay strategy to screen for modulators of the microRNA 21 biogenesis pathway.

David Shum, Bhavneet Bhinder, Constantin Radu, Thalia Farazi, Markus Landthaler, Thomas Tuschl, Paul Calder, Christina N Ramirez, Hakim Djaballah

Erratum issuedOpen access · greenAbstract read
In one paragraph

Article in Combinatorial chemistry & high throughput screening, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.4field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Small molecules targeting microRNA for cancer therapy: Promises and obstacles.Journal of controlled release : official journal of the Controlled Release Society · 2015
    Review
  3. An overview of microRNAs.Advanced drug delivery reviews · 2015
    Review
  4. Article
  5. Article
  6. A high content assay to assess cellular fitness.Combinatorial chemistry & high throughput screening · 2014
    Article
  7. Article
  8. A novel high throughput 1536-well Notch1 γ -secretase AlphaLISA assay.Combinatorial chemistry & high throughput screening · 2013
    Article
  9. Article
  10. Article
4 · The record

Corrections and comments

  • Erratum issued
    Farazi, Thalia [added]; Landthaler, Markus [added]; Tuschl, Thomas [added]
5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

David ShumHTS Core Facility, Molecular Pharmacology and Chemistry Program, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA.
Bhavneet Bhinder
Constantin Radu
Thalia Farazi
Markus Landthaler
Thomas Tuschl
Paul Calder
Christina N Ramirez
Hakim Djaballah
Memorial Sloan Kettering Cancer Center · US

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Nicholas D Socci · 1985 to 2026
$347.4M
NCI NIH HHS 5 P30 CA008748-44NCI NIH HHS P30 CA008748
6 · The paper itself

Abstract

microRNAs (miRNAs) are evolutionary conserved, small endogenous non-coding, RNA molecules. Although their mode of action has been extensively studied, little is known about their biogenesis. As their altered expression has been implicated in many diseases, small molecules that would modulate their expression are sought after. They are generated through the concerted action of several complexes which promote their transcription, maturation, export, trafficking, and loading of mature miRNA into silencing complexes. An increasing number of studies have suggested that each of these steps serves as a regulatory junction in the process, and therefore provides an intervention point. For this purpose, we have developed a simple image-based assay strategy to screen for such modulators. Here, we describe its successful implementation which combines the use of a microRNA 21 (miR-21) synthetic mimic together with an EGFP based reporter cell line, where its expression is under the control of miR-21, to monitor EGFP expression in a format suitable for HTS. The strategy was further validated using a small panel of known gene modulators of the miRNA pathway. A screen was performed in duplicate against a library of 6,912 compounds and identified 48 initial positives exhibiting enhanced EGFP fluorescence intensity. 42 compounds were found to be inherently fluorescent in the green channel leaving the remaining 6 as potential inhibitors and with a positive rate of 0.09%. Taken together, this validated strategy offers the opportunity to discover novel and specific inhibitors of the pathway through the screening of diverse chemical libraries.

Indexed as

Biosensing TechniquesHigh-Throughput Screening AssaysCells, CulturedHeLa CellsHumansMicroRNAsSmall Molecule LibrariesMicroRNAsMIRN21 microRNA, humanSmall Molecule Libraries

Identifiers

PMID22540737
PMCPMC3640486
OpenAlexW2111133104

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.